182 related articles for article (PubMed ID: 25636478)
21. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
[TBL] [Abstract][Full Text] [Related]
23. The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.
Nguyen NQ; Castermans K; Berndt S; Herkenne S; Tabruyn SP; Blacher S; Lion M; Noel A; Martial JA; Struman I
PLoS One; 2011; 6(11):e27318. PubMed ID: 22087289
[TBL] [Abstract][Full Text] [Related]
24. Tumor vasculature: a sally port for inhibiting cancer cell spreading.
Qian CN; Pezzella F
Cancer Commun (Lond); 2018 Aug; 38(1):52. PubMed ID: 30075743
[TBL] [Abstract][Full Text] [Related]
25. Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy.
Sato Y
Cancer Sci; 2011 Jul; 102(7):1253-6. PubMed ID: 21401807
[TBL] [Abstract][Full Text] [Related]
26. The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature.
Fenton BM; Paoni SF
Cancer Res; 2007 Oct; 67(20):9921-8. PubMed ID: 17942924
[TBL] [Abstract][Full Text] [Related]
27. Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy.
Franco M; Pàez-Ribes M; Cortez E; Casanovas O; Pietras K
Horm Metab Res; 2011 Nov; 43(12):884-9. PubMed ID: 21960459
[TBL] [Abstract][Full Text] [Related]
28. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional optical imaging of angiogenesis in animal models.
Roberts RL; Lin PC
Methods Enzymol; 2004; 386():105-22. PubMed ID: 15120248
[No Abstract] [Full Text] [Related]
30. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation.
Garmy-Susini B; Jin H; Zhu Y; Sung RJ; Hwang R; Varner J
J Clin Invest; 2005 Jun; 115(6):1542-51. PubMed ID: 15902308
[TBL] [Abstract][Full Text] [Related]
31. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Raza A; Franklin MJ; Dudek AZ
Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
[TBL] [Abstract][Full Text] [Related]
32. Evaluating tumor angiogenesis.
Uh MK; Kandel J; Kitajewski J
Methods Mol Biol; 2013; 980():341-51. PubMed ID: 23359165
[TBL] [Abstract][Full Text] [Related]
33. Pericytes: a double-edged sword in cancer therapy.
Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
[TBL] [Abstract][Full Text] [Related]
34. Real-time visualization and characterization of tumor angiogenesis and vascular response to anticancer therapies.
Xing HR; Zhang Q
Methods Mol Biol; 2012; 872():115-27. PubMed ID: 22700407
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
[TBL] [Abstract][Full Text] [Related]
36. Deeper penetration into tumor tissues and enhanced in vivo antitumor activity of liposomal paclitaxel by pretreatment with angiogenesis inhibitor SU5416.
Yoshizawa Y; Ogawara K; Fushimi A; Abe S; Ishikawa K; Araki T; Molema G; Kimura T; Higaki K
Mol Pharm; 2012 Dec; 9(12):3486-94. PubMed ID: 23134499
[TBL] [Abstract][Full Text] [Related]
37. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the "blood-tumor" barrier improves immunotherapy.
Manzur M; Hamzah J; Ganss R
Cell Cycle; 2008 Aug; 7(16):2452-5. PubMed ID: 18719382
[TBL] [Abstract][Full Text] [Related]
39. VEGF-A: a critical regulator of blood vessel growth.
Ferrara N
Eur Cytokine Netw; 2009 Dec; 20(4):158-63. PubMed ID: 20167554
[TBL] [Abstract][Full Text] [Related]
40. Optical imaging and tumor angiogenesis.
Lin PC
J Cell Biochem; 2003 Oct; 90(3):484-91. PubMed ID: 14523982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
